Stivarga (regorafenib)

pCPA File Number: 20931
Negotiation Status:
Concluded with an LOI
Indication(s):
Gastrointestinal Stromal Tumours
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: